Literature DB >> 25994755

Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment.

Fumiyuki Otsuka1, Robert A Byrne2, Kazuyuki Yahagi1, Hiroyoshi Mori1, Elena Ladich1, David R Fowler3, Robert Kutys1, Erion Xhepa2, Adnan Kastrati2, Renu Virmani1, Michael Joner4.   

Abstract

Despite the reduction in late thrombotic events with newer-generation drug-eluting stents (DES), late stent failure remains a concern following stent placement. In-stent neoatherosclerosis has emerged as an important contributing factor to late vascular complications including very late stent thrombosis and late in-stent restenosis. Histologically, neoatherosclerosis is characterized by accumulation of lipid-laden foamy macrophages within the neointima with or without necrotic core formation and/or calcification. The development of neoatherosclerosis may occur in months to years following stent placement, whereas atherosclerosis in native coronary arteries develops over decades. Pathologic and clinical imaging studies have demonstrated that neoatherosclerosis occurs more frequently and at an earlier time point in DES when compared with bare metal stents, and increases with time in both types of implant. Early development of neoatherosclerosis has been identified not only in first-generation DES but also in second-generation DES. The mechanisms underlying the rapid development of neoatherosclerosis remain unknown; however, either absence or abnormal endothelial functional integrity following stent implantation may contribute to this process. In-stent plaque rupture likely accounts for most thrombotic events associated with neoatherosclerosis, while it may also be a substrate of in-stent restenosis as thrombosis may occur either symptomatically or asymptomatically. Intravascular optical coherence tomography is capable of detecting neoatherosclerosis; however, the shortcomings of this modality must be recognized. Future studies should assess the impact of iterations in stent technology and risk factor modification on disease progression. Similarly, refinements in imaging techniques are also warranted that will permit more reliable detection of neoatherosclerosis. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Coronary disease; Imaging; Neoatherosclerosis; Pathology; Restenosis; Stents; Thrombosis

Mesh:

Year:  2015        PMID: 25994755     DOI: 10.1093/eurheartj/ehv205

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  65 in total

Review 1.  Endothelial Repair and Regeneration Following Intimal Injury.

Authors:  Belay Tesfamariam
Journal:  J Cardiovasc Transl Res       Date:  2016-01-21       Impact factor: 4.132

2.  Shedding light on the mechanisms of stent thrombosis with optical coherence tomography.

Authors:  Johannes Nicolaas van der Sijde; Evelyn Regar
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

3.  Neoatherosclerosis assessed with optical coherence tomography in restenotic bare metal and first- and second-generation drug-eluting stents.

Authors:  Lei Song; Gary S Mintz; Dong Yin; Myong Hwa Yamamoto; Chee Yang Chin; Mitsuaki Matsumura; Khady Fall; Ajay J Kirtane; Manish A Parikh; Jeffrey W Moses; Ziad A Ali; Richard A Shlofmitz; Akiko Maehara
Journal:  Int J Cardiovasc Imaging       Date:  2017-03-09       Impact factor: 2.357

4.  Differences between first-generation and second-generation drug-eluting stent regarding in-stent neoatherosclerosis characteristics: an optical coherence tomography analysis.

Authors:  Norihiro Kobayashi; Yoshiaki Ito; Masahiro Yamawaki; Motoharu Araki; Tsuyoshi Sakai; Masaru Obokata; Yasunari Sakamoto; Shinsuke Mori; Masakazu Tsutsumi; Masahiro Nauchi; Yohsuke Honda; Takahiro Tokuda; Kenji Makino; Shigemitsu Shirai; Keisuke Hirano
Journal:  Int J Cardiovasc Imaging       Date:  2018-05-21       Impact factor: 2.357

5.  Coronary stent thrombosis: what have we learned?

Authors:  Carlos Collet; Yohei Sotomi; Rafael Cavalcante; Pannipa Suwannasom; Erhan Tenekecioglu; Yoshinobu Onuma; Patrick W Serruys
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

6.  Coronary plaque characteristics on baseline CT predict the need for late revascularization in symptomatic patients after percutaneous intervention.

Authors:  Mengmeng Yu; Zhigang Lu; Wenbin Li; Meng Wei; Jing Yan; Jiayin Zhang
Journal:  Eur Radiol       Date:  2018-02-15       Impact factor: 5.315

Review 7.  Mechanisms of drug-eluting stent restenosis.

Authors:  Jiro Aoki; Kengo Tanabe
Journal:  Cardiovasc Interv Ther       Date:  2020-11-21

Review 8.  Drug-eluting stent thrombosis: current and future perspectives.

Authors:  Shoichi Kuramitsu; Shinjo Sonoda; Kenji Ando; Hiromasa Otake; Masahiro Natsuaki; Reo Anai; Yasuhiro Honda; Kazushige Kadota; Yoshio Kobayashi; Takeshi Kimura
Journal:  Cardiovasc Interv Ther       Date:  2021-01-13

9.  Time-Varying Outcomes With the Absorb Bioresorbable Vascular Scaffold During 5-Year Follow-up: A Systematic Meta-analysis and Individual Patient Data Pooled Study.

Authors:  Gregg W Stone; Takeshi Kimura; Runlin Gao; Dean J Kereiakes; Stephen G Ellis; Yoshinobu Onuma; Bernard Chevalier; Charles Simonton; Ovidiu Dressler; Aaron Crowley; Ziad A Ali; Patrick W Serruys
Journal:  JAMA Cardiol       Date:  2019-12-01       Impact factor: 14.676

Review 10.  Characterization of coronary atherosclerosis by intravascular imaging modalities.

Authors:  Satoshi Honda; Yu Kataoka; Tomoaki Kanaya; Teruo Noguchi; Hisao Ogawa; Satoshi Yasuda
Journal:  Cardiovasc Diagn Ther       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.